Search

Your search keyword '"Fujishima, Yoshimi"' showing total 3 results
Start Over Author "Fujishima, Yoshimi" Journal molecular and clinical oncology
3 results on '"Fujishima, Yoshimi"'

1. Secondary CIC‑rearranged sarcoma responsive to chemotherapy regimens for Ewing sarcoma: A case report

Author

Kimbara, Shiro, primary, Imamura, Yoshinori, additional, Kiyota, Naomi, additional, Takakura, Hidetomo, additional, Matsumoto, Sakuya, additional, Koyama, Taiji, additional, Fujishima, Yoshimi, additional, Funakoshi, Yohei, additional, Toyoda, Masanori, additional, Hirose, Takanori, additional, Kanzawa, Maki, additional, Kawamoto, Teruya, additional, Hara, Hitomi, additional, and Minami, Hironobu, additional

Published
2021
Full Text
View/download PDF

3. Regorafenib-induced exacerbation of chronic immune thrombocytopenic purpura in remission: A case report.

Author

Kimbara S, Imamura Y, Yakushijin K, Higashime A, Koyama T, Fujishima Y, Funakoshi Y, Toyoda M, Kiyota N, Matsuoka H, and Minami H

Abstract

Regorafenib is an oral multi-kinase inhibitor which targets tumor angiogenesis, the tumor microenvironment and oncogenesis. Based on this mode of action, regorafenib has a broad spectrum of toxicities. However, at present, few reports have focused on autoimmune adverse events. We report a first case of regorafenib-induced exacerbation of chronic immune thrombocytopenic purpura in remission during treatment for the patients with heavily treated advanced colorectal cancer. This case report highlights the need for caution with regard to regorafenib treatment in patients with cancer with concomitant immune thrombocytopenic purpura., (Copyright: © Kimbara et al.)

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results